Jean Patterson, Ph.D.
Adjunct Professor
Department of Microbiology
Immunology & Molecular Genetics
Since the anthrax attacks in 2001, the U.S. government has been committed to developing countermeasures to potential biological weapons, now referred to as select agents. Texas Biomed has had a BSL4 maximum containment laboratory since 2000. Dr. Patterson’s laboratory has worked on the development of countermeasures against many select agents. Her group works to develop therapies and vaccines against naturally occurring pathogens that can cause sporadic but lethal outbreaks. She has helped develop three vaccines against Ebola, one with Emory University and one with Crucell pharmaceuticals and one with Bavarian Nordic, all are undergoing further studies.
Areas of Research: Virol Pathogenesis and Vaccine Development Research
Associated Diseases: Ebola, Zika viruses
Techniques Used: Viral culture, molecular detection techniques and immunology assessments